Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06185816 · ClinicalTrials.gov registry record · Phase 2
Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain
A Phase 2 study, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 95
- Enrollment target
NCT06185816: Recruiting Phase 2 study, sponsored by Stanford University.
NCT06185816 is a Phase 2 study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06185816, a Phase 2 study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to examine non-invasive pulsed radiofrequency (NIPRF) and the effect it has on chronic neuropathic pain. Chronic neuropathic pain after peripheral nerve injury most often occurs in the context of post-traumatic or post-surgical pain. It is often treated with nerve blocks, prescription medication, physical therapy, neuromodulation, and surgery. The study team will be examining the efficacy of NIPRF and determining if it would be an appropriate treatment for chronic neuropathic pain after peripheral nerve injury.The Stimpod used in the present study is FDA approved and will be used for on label purposes.
Interventions
- DEVICE Active Treatment
- DEVICE Non-active Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2029-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06185816
The ClinicalTrials.gov registry entry for NCT06185816 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Treatment is the first listed.
NCT06185816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06185816 about?
NCT06185816 is a clinical study titled "Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain". The purpose of this study is to examine non-invasive pulsed radiofrequency (NIPRF) and the effect it has on chronic neuropathic pain. Chronic neuropathic pain after peripheral nerve injury most often occurs in the context of post-traumatic or post-surgical pain. It is often treated with nerve blocks...
What is the current status of trial NCT06185816?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2024-11-01. Estimated completion is 2029-01-01.
What interventions are being tested in trial NCT06185816?
The interventions under investigation include: Active Treatment (DEVICE), Non-active Treatment (DEVICE).
Who is sponsoring clinical trial NCT06185816?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.